Felicity Goodyear-Smith1, Joan Halliwell. 1. Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand. f.goodyear-smith@auckland.ac.nz
Abstract
OBJECTIVE: To summarize the available evidence on the use of anticonvulsant drugs for the treatment of various conditions of neuropathic pain. METHODS: This is a systematic review on quantity and quality of evidence for using anticonvulsants in the management of neuropathic pain. Medical Subject Heading terms searched were "anticonvulsants" and "pain." Data sources used were the Cochrane Controlled Trials Register, Cochrane Database of Systematic Reviews, Medline 1966 to May 2006, Embase 1980 to May 2006, and CINAHL 1982 to May 2006. Additional studies were identified by hand searching the reference lists of retrieved papers and by autoalerts subsequent to May 2006. Randomized controlled trials, systematic reviews, and meta-analyses included. Non-English papers excluded. Evidence and evidence gaps with regard to specific conditions and drugs identified. RESULTS: Concise summary of all existing evidence or lack thereof was produced. A succinct table is presented of the efficacy of specific drugs for specific conditions and the nature and quality of evidence. The paper outlines the incidence of specific neuropathic pain conditions within various population groups and assesses the quantity of available evidence in regard to the frequency that those conditions are likely to occur. DISCUSSION: Gaps in the evidence are striking. Recommendations directly supported by the evidence by drug and by condition are made.
OBJECTIVE: To summarize the available evidence on the use of anticonvulsant drugs for the treatment of various conditions of neuropathic pain. METHODS: This is a systematic review on quantity and quality of evidence for using anticonvulsants in the management of neuropathic pain. Medical Subject Heading terms searched were "anticonvulsants" and "pain." Data sources used were the Cochrane Controlled Trials Register, Cochrane Database of Systematic Reviews, Medline 1966 to May 2006, Embase 1980 to May 2006, and CINAHL 1982 to May 2006. Additional studies were identified by hand searching the reference lists of retrieved papers and by autoalerts subsequent to May 2006. Randomized controlled trials, systematic reviews, and meta-analyses included. Non-English papers excluded. Evidence and evidence gaps with regard to specific conditions and drugs identified. RESULTS: Concise summary of all existing evidence or lack thereof was produced. A succinct table is presented of the efficacy of specific drugs for specific conditions and the nature and quality of evidence. The paper outlines the incidence of specific neuropathic pain conditions within various population groups and assesses the quantity of available evidence in regard to the frequency that those conditions are likely to occur. DISCUSSION: Gaps in the evidence are striking. Recommendations directly supported by the evidence by drug and by condition are made.
Authors: Misty D Smith; Jose H Woodhead; Laura J Handy; Timothy H Pruess; Fabiola Vanegas; Erin Grussendorf; Joel Grussendorf; Karen White; Karolina K Bulaj; Reisa K Krumin; Megan Hunt; Karen S Wilcox Journal: Neurochem Res Date: 2017-05-15 Impact factor: 3.996
Authors: Christine Sanderson; Stephen J Quinn; Meera Agar; Richard Chye; Katherine Clark; Matthew Doogue; Belinda Fazekas; Jessica Lee; Melanie R Lovell; Debra Rowett; Odette Spruyt; David C Currow Journal: BMJ Support Palliat Care Date: 2014-10-16 Impact factor: 3.568
Authors: Sohail M Mulla; D Norman Buckley; Dwight E Moulin; Rachel Couban; Zain Izhar; Arnav Agarwal; Akbar Panju; Li Wang; Sun Makosso Kallyth; Alparslan Turan; Victor M Montori; Daniel I Sessler; Lehana Thabane; Gordon H Guyatt; Jason W Busse Journal: BMJ Open Date: 2014-11-20 Impact factor: 2.692
Authors: Brigitte A Brouwer; Bianca T A de Greef; Janneke G J Hoeijmakers; Margot Geerts; Maarten van Kleef; Ingemar S J Merkies; Catharina G Faber Journal: Drugs Aging Date: 2015-08 Impact factor: 3.923
Authors: Marta Vázquez; Natalia Guevara; Cecilia Maldonado; Paulo Cáceres Guido; Paula Schaiquevich Journal: Biomed Res Int Date: 2020-08-13 Impact factor: 3.411